Cti Biopharma Corp

Ownership Transactions Reported by 11 Insiders

Location
3101 Western Avenue, Suite 800, Seattle, Washington

There are no Buy or Sell transactions made by insiders since 8/27/2023

Cti Biopharma Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bruce J. Seeley EVP, Chief Operating Officer $400K Jun 30, 2021
Adam R. Craig President and CEO, Director Jun 26, 2023
Michael A. Metzger Director Jun 26, 2023
Bvf Partners L P/Il Director, Other*, 10%+ Owner Jun 26, 2023
James K. Fong EVP & Chief Commercial Officer Jun 26, 2023
Diane Parks Director Jun 26, 2023
Laurent Fischer Director Jun 26, 2023
David Parkinson Director Jun 26, 2023
Matthew Perry Director Jun 26, 2023
Reed Vaughn Tuckson Director Jun 26, 2023
David Kirske EVP, Chief Financial Officer Jun 26, 2023

Recent Insider Transactions by Companies or Individuals for Cti Biopharma Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.